Four years after Kevin T. Conroy took the top job at a struggling biotech company, Exact Sciences Corp. said Monday it has submitted an application to federal regulators for approval to market a DNA-based, non-invasive colon cancer test. Read the full Milwaukee Journal Sentinel story here.
- BizTimes: Wages are the bright spot in Wisconsin’s employment pictureNovember 20, 2019
- WisBusiness: Legislature passes bills related to startup funding, oversightNovember 18, 2019
- WisconsinINNO: Meet the 3 Startups That Took Home Trophies at Wisconsin Tech Council’s Pitch OlympicsNovember 18, 2019
- Bipartisan bills tied to investing, UW startups on way to governor after passing LegislatureNovember 14, 2019
- InsideWis: Are Janesville and Monona, Wis., the center of the fusion world? They may well beNovember 14, 2019